Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

Original Reports, Reviews and Editorials.

Editor
Alnawaz Rehemtulla
University of Michigan
Editorial Board
David G. Beer
University of Michigan
Edgar Ben-Josef
Perelman Center for Advanced Medicine
James A. Bonner
Wallace Tumor Institute
Dean Brenner
University of Michigan
Jan C Buckner
Mayo Clinic
James C. S Chim
The University of Hong Kong
Norman C. Coleman
National Institute of Health (NIH)
Joseph N. Contessa
Yale Cancer Center
Theodore DeWeese
Johns Hopkins Cancer Center
Kenneth Dornfeld
University of Minnesota
Raymond Dubois
University of Texas M.D. Anderson Cancer Center
Avraham Eisbruch
University of Michigan
Eric Fearon
University of Michigan
Daniel Hayes
University of Michigan
Donald Kufe
Dana-Farber Cancer Institute
Chandan Kuman
University of Michigan
El-Nasir Lalani
Aga Khan University
Frederick F. Lang
MD Anderson Cancer Center
C Ling
Memorial Sloan-Kettering Cancer Center
John Minna
University of Texas Southwestern Medical Center
William G. Nelson
Johns Hopkins University
Harvey I. Pass
New York University (NYU) Medical Center
Philip A. Philip
Karmanos Cancer Instit.
Kenneth Pienta
University of Michigan
Anthony Shields
Karmanos Cancer Instit.
Moshe Talpaz
University of Michigan
Randall K Ten Haken
University of Michigan
Ralph Weischebaum
University of Chicago
Christopher Willett
Duke University Medical Center
Terence Williams
Ohio State University Medical Center